BIOS BioPlus Acquisition Corporation

BioScrip, Inc. (Nasdaq: BIOS) today announced that it will present at the BMO Capital Markets Focus on Healthcare 2008 Investor Conference, to be held August 5-6, 2008, at the Millennium Broadway Hotel in New York City. BioScrip's Chairman and CEO, Richard H. Friedman, and Stanley G. Rosenbaum, Executive Vice President and CFO will present Tuesday, August 5th at 9:00 a.m. ET (Eastern Time). Investors may access the live audio webcast of BioScrip's presentation at the following link: http://www.bmocm.com/conferences/2008healthcare/webcast/default.aspx. The webcast replay of the presentation may also be accessed via the company�s website at www.bioscrip.com under the Investors section. About BioScrip, Inc. BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex healthcare conditions.